Location:Home /  Resource
Past list
CoolMPS™ and the non-coding Alzheimer's transcriptome: A 10-billion read puzzle
Release date:2019-12-17Writer:MGIViews:3422Share

Dr. Keller, who is doing research at Saarland and Stanford University is trying to understand how Alzheimer's and Parkinson's develop in the human body at small non coding RNA(sncRNA) level. Dr. Keller shows results of his research using alpha version of CoolMPS™ sequencing chemistry, where he finds CoolMPS™ provides a higher Q30 value -- the quality for each single base is much higher and the likelihood of wrong base calling is much lower in the new chemistry. High correlation has also been observed between the CoolMPS™ chemistry and existing data, which enables him to conduct quantitative analysis of new sncRNAs.

Dr. Andreas Keller
Dr. Andreas Keller
Department of Neurology and Neurological Sciences, Stanford University Chair for Clinical Bioinformatics, Saarland University


If you have any questions, you can send an email to:
MGI_marketing@mgi-tech.com
  • Hotline (Global)
    +86-4000-688-114
  • Email
    MGI-service@mgi-tech.com
  • Special Recommendations
  • *For research use only.

    Not for use in diagnostic procedures (except as specifically noted).
Copyright © 2024 All Rights Reserved MGI Tech Co., Ltd. Guangdong ICP 16117185Privacy PolicyLegal NoticesCookie Policy
Our use of cookies
We would like to use necessary cookies to improve your browsing experience and the quality of our website. We would also like to set analytics cookies and advertisement cookies that help us make improvements by measuring how you use our website. Detailed information about the use of cookies on this website and how you can control your consent can be found in our Cookie Policy and Privacy Policy.
Accept only strictly necessary cookiesAccept all cookies